Search - tctmd.com

Displaying 1 - 20 of 68

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1305: Evolut FX+ Implantation With a Protruding Left Main Coronary Stent

Presenter: Stephane Noble

October 26, 2025

Presentation NY Valves 2025

Optimizing Outflow During Redo-TAVR With a 23 mm Sapien UR for a Degenerated Evolut PRO 26 mm Valve

Presenter: Srivatsan Swaminathan

June 26, 2025

Presentation NY Valves 2025

Outcomes from the Optimize PRO Evolut FX System Addendum Study: 30-Day and 1-Year Results

Presenter: Hemal Gada

June 25, 2025

Presentation TCT 2024

The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based)

Presenter: Alexandre Abizaid

October 29, 2024

Presentation TCT 2024

TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry

Presenter: Anthony Matta

October 28, 2024

Presentation NY Valves 2024

Interventional Imaging: The Evolution Procedural Imaging Tools

Presenter: Rebecca T. Hahn

June 07, 2024

Presentation NY Valves 2024

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: John K. Forrest

June 07, 2024

Presentation TCT 2023

Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves

Presenter: Steven Yakubov

October 25, 2023

Presentation TCT 2023

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

Presenter: Guilherme Attizzani

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

Presentation TCT 2023

TCT 383: Feasibility of TAV-in-TAV in Evolut valves using in-vivo CT sizing and its impact on coronary obstruction and patient prosthesis mismatch

Presenter: Atsushi Okada

October 24, 2023

Presentation TVT 2023

Real-World Early Outcomes of Evolut FX Versus PRO+ Transcatheter Aortic Valve Replacement

Presenter: Wah Wah Htun

June 09, 2023

Presentation TVT 2023

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

Presenter: Amit Vora

June 08, 2023

Presentation TVT 2023

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

Presenter: Amit Vora

June 07, 2023

Presentation Miami Valves 2023

Evolution of ICD Therapy: 50 Years of Progress

Presenter: Sanjeev Saksena

February 03, 2023

Presentation TCT 2022

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Presenter: Reda Ibrahim

September 18, 2022

Presentation TCT 2022

EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)

Presenter: John Forrest

September 17, 2022

Presentation TVT 2022

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Presenter: Reda Ibrahim

June 10, 2022

Presentation TVT 2022

Proven Safety through MitraClip G4 and Evolution of TEER

Presenter: Rahul Sharma

June 09, 2022

Presentation TVT 2022

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries

Presenter: Andrea Scotti

June 09, 2022

Advertisement

TCT 1305: Evolut FX+ Implantation With a Protruding Left Main Coronary Stent

Optimizing Outflow During Redo-TAVR With a 23 mm Sapien UR for a Degenerated Evolut PRO 26 mm Valve

Outcomes from the Optimize PRO Evolut FX System Addendum Study: 30-Day and 1-Year Results

The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based)

TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry

Interventional Imaging: The Evolution Procedural Imaging Tools

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

TCT 383: Feasibility of TAV-in-TAV in Evolut valves using in-vivo CT sizing and its impact on coronary obstruction and patient prosthesis mismatch

Real-World Early Outcomes of Evolut FX Versus PRO+ Transcatheter Aortic Valve Replacement

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

Evolution of ICD Therapy: 50 Years of Progress

Patient Selection for PFO Closure in 2022: An Evolutionary Process

EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Proven Safety through MitraClip G4 and Evolution of TEER

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content